Last updated: March 20, 2024
Sponsor: Federico II University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Congestive Heart Failure
Circulation Disorders
Cardiomyopathy
Treatment
Molecular and genetic screening
Clinical Study ID
NCT05878041
PNRR-MR1-2022-12376858
Ages > 18 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria
Development of HF signs or symptoms in the last month of pregnancy or within 5 months of delivery;
Left ventricle systolic dysfunction demonstrated by classical echocardiographic criteria (LVEF< 45 %) in the last month of pregnancy or within 5 months of delivery.
Exclusion Criteria
Presence of any identifiable cause of HF;
Presence of recognizable heart disease before the last month of pregnancy.
Study Design
Total Participants: 40
Treatment Group(s): 1
Primary Treatment: Molecular and genetic screening
Phase:
Study Start date:
February 21, 2024
Estimated Completion Date:
May 19, 2026
Study Description
Connect with a study center
Federico II University Hospital
Naples, 80131
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.